European Psychiatry: Volume 15 -

European Psychiatry

Only show content I have access to (997)

Over 3 years (1069)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Volume 15 - October 2000

Posters, Monday, 30 October 2000

Symposia

P02.304 Predicting outcome of first episodes of schizophrenia

P02.305 A comparison of English and Italian drug legislation, their policies of intervention and any consequences upon stress and burnout at work

P02.306 Smooth pursuit eye movement (SPEM) in bulimia nervosa

P02.307 Alexithymia correction at hypertension patients with affective disoders

P02.308 Psychiatric co-morbidity among amphetamine users: Relations to amphetamine-induced psychosis

P02.309 Psychiatric morbidity among juvenile drug offenders

P02.310 Working with schizophrenic people: Informations to their families

P02.311 Coping strategies in relatives of patients with schizophrenia

P02.312 Violence and crime: Psychiatric approach

P02.313 Forensic psychiatric study of sexual abuse

P02.314 The wessex recent inpatient suicide study: 1. Case-control study of 234 recently discharged psychiatric inpatient suicides

P02.315 The wessex recent inpatient study: 2. Case-control study of 59 inpatient suicides

P02.316 Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (efeso study)

P02.317 Olanzapine versus risperidone: A prospective comparison of clinical and economic outcomes in schizophrenia

P02.318 Global index of safety (GIS): A new instrument to assess drug safety: Application to a prospective pharmacoepidemiological study (EFESO)

P02.319 Antipsychotic treatment, adverse events and health-related quality of life

P02.320 Safety and effectiveness of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (Europa study)

P02.322 Effectiveness of biological and non biological treatments in schizophrenia

P02.321 Occurrence of CYP2D6 gene duplication in Hong Kong Chinese

P02.323 Autonomic disturbance in malignant catatonia

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Volume 15 - October 2000

Posters, Monday, 30 October 2000

Symposia